8-K
filed October 7, 2024, 7:59 PM ET
CIK 0001098880
M&A
confidence high
sentiment negative
materiality 0.95
IntelGenx Technologies Corp.: M&A transaction — IntelGenx Technologies completes acquisition by atai Life Sciences via credit bid; executives and board resign
IntelGenx Technologies Corp.
- On Sept 30, 2024, Superior Court of Québec approved a credit-bid acquisition by atai Life Sciences AG of all IntelGenx Corp. shares.
- Transaction closed Oct 2, 2024; atai used its senior secured debt as consideration; no cash or equity exchanged.
- Shareholders of IntelGenx Technologies will receive no payments; ResidualCo and New ParentCo expected to file for bankruptcy.
- CEO Dwight Gorham, CFO Andre Godin, and Corporate Secretary Ingrid Zerbe resigned on Oct 2, 2024.
- Entire board including Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dwight Gorham resigned as Chief Executive Officer at IntelGenx Technologies Corp..
- Action
- resigned
- Role
- Chief Executive Officer
Exact text from the filing
O n October 2, 2024, Dwight Gorham, Chief Executive Officer of the Company, Andre Godin, Chief Financial Officer of the Company, and Ingrid Zerbe, Corporate Secretary of the Company, resigned from their respective positions.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Horst G. Zerbe resigned as Director at IntelGenx Technologies Corp..
- Action
- resigned
- Role
- Director
Exact text from the filing
O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the "Resignations").
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dwight Gorham resigned as Director at IntelGenx Technologies Corp..
- Action
- resigned
- Role
- Director
Exact text from the filing
O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the "Resignations").
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Mark Nawacki resigned as Director at IntelGenx Technologies Corp..
- Action
- resigned
- Role
- Director
Exact text from the filing
O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the "Resignations").
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Monika Trzcinska resigned as Director at IntelGenx Technologies Corp..
- Action
- resigned
- Role
- Director
Exact text from the filing
O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the "Resignations").
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ingrid Zerbe resigned as Corporate Secretary at IntelGenx Technologies Corp..
- Action
- resigned
- Role
- Corporate Secretary
Exact text from the filing
O n October 2, 2024, Dwight Gorham, Chief Executive Officer of the Company, Andre Godin, Chief Financial Officer of the Company, and Ingrid Zerbe, Corporate Secretary of the Company, resigned from their respective positions.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Andre Godin resigned as Chief Financial Officer at IntelGenx Technologies Corp..
- Action
- resigned
- Role
- Chief Financial Officer
Exact text from the filing
O n October 2, 2024, Dwight Gorham, Chief Executive Officer of the Company, Andre Godin, Chief Financial Officer of the Company, and Ingrid Zerbe, Corporate Secretary of the Company, resigned from their respective positions.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Bernd J. Melchers resigned as Director at IntelGenx Technologies Corp..
- Action
- resigned
- Role
- Director
Exact text from the filing
O n October 2, 2024, Horst G. Zerbe, Dwight Gorham, Bernd J. Melchers, Mark Nawacki, and Monika Trzcinska resigned from the Board of Directors, effectively immediately (the "Resignations").
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
IntelGenx Technologies Corp. completed a disposition involving atai Life Sciences AG for senior secured debt in the Company was discharged in exchange for IGX shares (closed 2024-10-02).
- Action
- disposition
- Counterparty
- atai Life Sciences AG
- Consideration
- senior secured debt in the Company was discharged in exchange for IGX shares
- Closing
- 2024-10-02
Exact text from the filing
Pursuant to the Transaction, which closed on October 2, 2024, atai acquired all of the issued and outstanding shares of IGX.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.